Diflunisal is an anti-inflammatory non-steroidal drug, class II of the Biopharmaceutical Classification System, that has recently been the subject of renewed interest due to its potential use in the oral therapy of familial amyloid polyneuropathy. In this work, a thermodynamic based approach is used to investigate binary mixtures (diflunisal + picolinamide) and (diflunisal + isonicotinamide) in order to identify solid forms potentially useful to improve the biopharmaceutical performance of this active pharmaceutical ingredient.
Introduction
Co-crystals [1] [2] [3] [4] [5] [6] have been the subject of intense research in the last decade, due to their great potential for practical applications in several domains, 7, 8 especially when active pharmaceutical ingredients, APIs, are concerned 5, 9, 10 . Pharmaceutical co-crystals, combining an API and an acceptable co-former, 11 have the potential for enhancing the physical properties of the API, positively impacting its solubility, stability, oral bioavailability and processability, without compromising its biological function 1, 9, 12-21 .
Thus, co-crystal research formation spurs interest from pharmaceutical industry, especially for those APIs whose oral bioavailability is solubility limited, classes II and IV of the Biopharmaceutical Classification System (BCS) 22 . For this kind of drugs, besides cocrystals, binary eutectic mixtures, for instance, are also relevant [23] [24] [25] [26] due to their increased surface area and the potential for increasing dissolution rate. Therefore, the establishment of the binary solid-liquid phase diagrams of the API and the potential co-former is of considerable interest as it gives comprehensive information of the solid binary mixtures behavior.
Diflunisal, DIF, Figure 1 .a, BCS class II nonsteroidal anti-inflammatory drug, finds application in medical practice in oral formulations for the acute or long-term treatment of rheumatoid arthritis, osteoarthritis, or mild to moderate pain 27 , and research is currently been carried out on its use in familial amyloid polyneuropathy 28 . Pyridinecarboxamides such as nicotinamide, NA, and the isomeric picolinamide, PA, and isonicotinamide, INA, (Figure 1 ) are quite appealing as co-formers, CoF, for target compounds with carboxylic acid groups, as association through different supramolecular heterosynthons can occur, envisaging the possibility of formation of co-crystals of different stoichiometry 29 . In a previous study carried out by this research team on the DIF + NA system, a 2:1 co-crystal was identified 30, 31 , and the presence of the acidN-pyridine heterosynthon in the cocrystal structure was confirmed. Wang et al. 32 obtained a 2:1 DIF + NA co-crystal from equimolar ethanol solutions, and in the same experimental conditions a 2:1 DIF + INA cocrystal. PA and INA differ from nicotinamide just on the amide group position relatively to the ring nitrogen (ortho, para, meta, respectively in PA, INA and NA). The proximity between the amide hydrogen and the heterocyclic nitrogen in PA, enabling intramolecular hydrogen bonding, has been regarded to contribute to a lower ability of PA to co-crystal formation 33, 34 .
Thermodynamic and crystal engineering principles are of fundamental relevance in order to control and predict crystallization process outcomes and co-crystal properties.
Some work has been published concerning the use of solubility measurements and ternary phase diagrams for co-crystal formation prediction and for design of rational preparative procedures from solutions 30, [34] [35] [36] [37] [38] . A systematic study of co-crystal formation in series of structurally related co-formers will contribute to the identification of thermodynamic and crystal engineering principles for co-crystal production and application.
The current work therefore follows our interest in diflunisal multicomponent systems 11, 30, 31 , and on the different pyridinecarboxamides as co-formers 34 
Experimental

Materials and mixtures preparation
The starting materials were supplied by Aldrich with specified purify 0.99. XRPD confirmed diflunisal as the triclinic polymorph I 40 , and picolinamide as polymorph II 41, 42 .
The room temperature thermodynamic stable isonicotinamide polymorph II (reference code EHOW1H01) [43] [44] [45] [46] (results confirmed by XRPD).
Co-crystal screening
Crystal16 equipment by Avantium Technologies was used in order to determine saturation Ethanol was used, as it is a solvent of choice in pharmaceutical development: it belongs to class 3 of the residual solvents classification (low toxic potential) 42, 43 , allowing also to achieve adequate drying of the solid samples at low temperatures.
Differential scanning calorimetry(DSC)
The studies were performed on a PerkinElmer Pyris1 power compensation calorimeter with an intracooler cooling unit at 248 K (ethylene glycol + water, 1:1 (v/v), cooling mixture). The samples, mass ∼2 mg, were hermetically sealed in 30 μL aluminum pans, and an empty pan was used as reference. A 20 mL·min -1 nitrogen purge was employed.
Scanning rates β = 10 K·min -1 and β = 2 K·min -1 were used. Temperature calibration 47, 48 was performed with the high- 47 and verified with the fusion enthalpy of biphenyl (Δ fus H m = 18574 ± 4 J·mol -1 ) 47 and benzoic acid (Δ fus H m = 18063 ± 42 J·mol -1 ) 47 . The uncertainties of the measurements are estimated to be ± 0.2 K for temperature and ± 2 % for enthalpy.
Infrared spectroscopy (FTIR)
The IR spectra were collected, with 1 cm -1 spectral resolution, on a ThermoNicolet IR300 Fourier transform infrared spectrometer, equipped with a deuterated triglycine sulfate (DTGS) detector and a Ge/KBr beam splitter, using the KBr pellet technique.
X-ray Power diffraction (XRPD)
A Bruker-AXS D2 Phaser X-ray powder diffractometer, Bragg-Brentano geometry, was used with Ni-filtered Cu Kα ,(λ=1.54184 Å) radiation and a Lynxeye detector. A rotating glass capillary ENRAF-NONIUS powder diffractometer, equipped with a CPS120 detector by INEL, was also employed with data collection in Debye-Scherrer geometry, using monochromatized CuKα 1 radiation (λ = 1.540598 Å). Silicon was used as an external calibrant.
Results and discussion
Co-crystal screening
The ability of co-crystal formation of diflunisal (DIF) with isonicotinamide (INA) and picolinamide (PA) is confirmed by applying the methodology described by ter Horst et al. 34, 37 , using clear point temperature measurements of suspensions in ethanol. In a first step of this procedure, the solubility of the pure compounds in ethanol was determined. . If diflunisal and the co-formers are able to form a stable co-crystal, then the T s of the co-crystal in the mixed solutions should be higher than the T ref 37 . This was observed in both cases as shown in Figure 3 , where data for NA 30 were also included.
The observed temperature differences (T S -T ref ) are very high, above 48K for all three systems. This large temperature difference indicates not only that co-crystal formation is highly likely, but also that the resulting co-crystals are very stable. In the Xray powder diffractograms of the obtained recrystallized solids after the saturation temperature measurements, new reflections are further evidence that a new solid entity is formed ( Figure S2 , supplementary material). From the van't Hoff plots shown in Figure 2 for DIF:INA and DIF:PA in ethanol, the parameters presented in Table 1 were obtained. These were used to draw estimates of the isothermal ternary phase diagrams for DIF:INA and DIF:PA in ethanol at 298 K and 323 K, Figure 4 . Both co-crystals are very stable and may be obtained by addition of small amount of the co-formers to the API saturated solutions. The composition of the 3-phase equilibrium points shown in Figure 4 for the DIF+INA+ethanol system are (x DIF = 7.6x10 -4 ; From the phase diagram it is apparent that the compositional region for obtaining co-crystal is very large: there is thus a large freedom in the choice for solution composition during co-crystal production. The binary solid-liquid phase diagram for (DIF + INA) derived from DSC data is shown on Figure 6 . The solidus curve in the diagram is obtained from the onset temperature, T E , of the first peak and the liquidus curve from the peak temperature, T liq , of the last peak observed in each DSC thermogram 53, 54 . Maximum uncertainties on the temperature values are  0.8 %. These results are shown in table S1 for (diflunisal + isonicotinamide). The enthalpies of fusion of the eutectic peaks in the DSC curves of mixtures of different compositions were used to construct the triangular Tammann plots shown in Figure 7 .
(Solid + liquid) binary phase diagrams
Tammann plots are normally used in order to define the eutectic compositions and to evaluate the possibility of solid solution formation. 51, 55 The enthalpy values used in Figure   7 were obtained by deconvolution of the complex DSC curves registered at β = 2 K·min -1 (Uncertainties in these enthalpy values are at maximum  5%). For mixtures with x DIF ≤ 0.6667, Figure 7 .a, the sum of the enthalpies of both invariant temperature peaks at T E1~ 406 K and T E2 ~ 412. Assuming complete immiscibility in the solid phase and total miscibility in the liquid one, and that the enthalpy of fusion does not change in the temperature range considered, the liquidus temperatures T fus,i* for compositions where an excess of a pure component i is present can be calculated using eq.(2) 56 . Ideal behaviour was calculated, for diflunisal compositions between both eutectic points, using equation (3) 
Ideal behavior is represented in Figure 6 by the dotted lines.
Diflunisal + picolinamide
The DSC curves shown in Figure 8 The binary solid-liquid phase diagram of (DIF + Pa) shows negative deviation from ideal solution (dotted lines in Figure 9 ). Equation (4), a modification of equation (3) taking into account the stoichiometry of this particular co-crystal, was used to calculate ideal liquidus temperatures in the neighborhood of the co-crystal, between the two eutectic points. 
Values that range from γ DIF = 0.97 for x DIF = 0.9357 to γ DIF = 0.87 for x DIF = 0.7482, are obtained, from eq.(2), for mixtures richer in diflunisal, indicating also in this system, solution negative deviation from ideal behavior (dotted line in Figure 9 ). However, deviations from ideality are much lower in this system than for (DIF + INA) system, reflecting lower intermolecular between DIF and PA in the molten phase.
XRPD and FTIR characterization
The XRPD data presented in Figures 11.a and 11 .b for the (diflunisal + isonicotinamide) and (diflunisal + picolinamide) systems, respectively, clearly identifies new solid state 
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The FTIR spectra of the co-crystals formed by each of the three pyridinecarboxamide isomers and diflunisal are presented in Figure 12 .
The heterosynton formed by acid-N aromatic groups is identified in the three cocrystals by the characteristics bands at about 2500, 2150 and 1900 cm -1 26, 57-60 . There is a reduced number of co-crystals reported in literature using picolinamide as a co-former 33, 39 . In this isomer, the aromatic nitrogen, ortho relatively to the amide group, is, a priori, less prone to be involved in intermolecular interactions. However, it was observed that the aromatic nitrogen participates in N amide -H…N aromatic bonds in the crystal lattice of the picolinamide:salycilic acid co-crystal and also in the acid O-H…N aromatic bond in the cocrystal of picolinamide with adipic acid 33 . The infrared spectrum obtained in the current work points out to picolinamide association with diflunisal involving this latter heterosynthon.
However, in the NH 2 elongation region, significant differences are observed between the spectrum of the diflunisal:picolinamide co-crystal and those formed by diflunisal and the 3-and 4-pyridinecarboxamide isomers. In contrast, the IR spectra of the DIF:PA co-crystal are substantially different from those of DIF:INA and DIF:NA. In the DIF:PA co-crystal the asymmetric, ν as(NH 2 ), and the symmetric, ν s(NH 2 ), elongation modes are redshifted when compared to picolinamide spectrum: ν as(NH 2 ) and ν s(NH 2 ) have their maxima at 3417 and 3176cm -1 , respectively, in picolinamide, form II, which are shifted to 3394 cm -1 and 3106 cm -1 in the co-crystal.
Desiraju et al., 60 in their attempt to identify synthons in co-crystals and polymorphs using infrared spectroscopy, with a special focus on primary amides, associate deviations of NH 2 elongations frequencies to lower energies to the change in association from dimers to chains. Centrosymmetric amide-amide dimers are present in the crystalline structure of picolinamide. From the co-crystal infrared spectrum, and taking into account Desiraju et al. conclusions, the change to chain association is quite plausible.
The results show that, although co-crystals have been obtained for diflunisal with the three isomeric pyridinecarboxamides, the structural differences of the co-formers have an important influence in the supramolecular association, clearly distinguishing pyridine-2-carboxamide from the others.
Crystallization experiments
The ternary phase diagrams DIF-CoF-ethanol, Figure 4 , were used to design cocrystallization experiments in order to obtain the pure co-crystals. Solutions of appropriate composition were prepared at 323 K and then cooled to 298 K. The used solution compositions were chosen in the region marked by A in the diagrams -below line a-b that joins the pure components solubility at 298 K and also below the co-crystal solubility at 323 K. This procedure allowed the preparation of pure samples of the co-crystals described in this work as confirmed by XRPD and FTIR.
Data presented in Figure 4 , combined with the known co-crystals stoichiometry, allow the construction of the complete triangular ternary phase diagrams, at T = 298 K, presented Although the pure co-crystals were generated in the co-crystallization processes designed by the ternary phase diagrams, powder samples were always obtained. No single crystals, suitable for structure determination, could be produced, which, unfortunately, is not uncommon in the synthesis of co-crystals.
Subsequent experiments carried out in order to obtain single crystals of the two identified co-crystals were unsuccessful: crystallization from various solvents, methanol, 1-butanol, acetone, ethyl acetate, ethyleneglycol diethylether, tetrahydrofuran, acetonitrile, dimethylsulfoxide, p-xylene, with supersaturation achieved in different ways, and also with seeding with the co-crystals obtained by grinding was tried; crystallization from gel media was also tested 61 .
Conclusions
The thermodynamic approach used in the current work successfully predicts cocrystal formation between diflunisal and picolinamide and isonicotinamide, as it was found before for the other pyridinecarboxamide isomer, nicotinamide 30 and despite the differences of the co-former molecular structures. The solid-liquid binary phase diagrams
give conclusive evidence of co-crystals formation and of their stoichiometry: a (1:1) cocrystal with picolinamide, and a (2:1) co-crystal with isonicotinamide. The determined ternary phase diagrams enable the design of co-crystallization processes. 
